|Bid||117.90 x 800|
|Ask||134.88 x 800|
|Day's Range||117.22 - 121.20|
|52 Week Range||85.74 - 169.54|
|Beta (5Y Monthly)||1.41|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 03, 2023 - May 08, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||142.13|
Subscribe to Yahoo Finance Plus to view Fair Value for IRTC
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Additional studies presented at ACC.23/WCC reinforce the clinical value of the Zio suite of products and servicesSAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent disease, recently presented the results of multiple new studies at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology (ACC.23/WCC).
iRhythm continues to expand its strong body of clinical and scientific evidence with new research presented by leading clinical investigators at the conference Highlights include a retrospective analysis of comparative effectiveness between ambulatory monitors for arrhythmia diagnosis SAN FRANCISCO, March 02, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent disease, will hav